| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | MASTERCARD INCORPORATED | 5,405 | 511,000 | 0.01% | ||
| 252 | BROOKDALE SR LIVING INC | 27,019 | 429,000 | 0.01% | ||
| 253 | TOBIRA THERAPEUTICS INC | 50,000 | 409,000 | 0.01% | ||
| 254 | ADAPTIMMUNE THERAPEUTICS PLC | 50,000 | 407,000 | 0.01% | ||
| 255 | LEXICON PHARMACEUTICALS | 30,000 | 359,000 | 0.01% | ||
| 256 | CEMPRA INC | 20,000 | 350,000 | 0.01% | ||
| 257 | CONATUS PHARMACEUTICALS INC COM | 156,531 | 335,000 | 0.01% | ||
| 258 | OCULAR THERAPEUTIX INC | 30,000 | 290,000 | 0.01% | ||
| 259 | Nabriva Therapeutics AG | 30,000 | 269,000 | 0.01% | ||
| 260 | XILINX INC | 5,147 | 244,000 | 0.00% | ||
| 261 | VERMILLION INC | 100,000 | 147,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003362, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
